Received Apr 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | IM |
Intentional Age Prescription by HCP: The patient is 76 years old. Per package insert, Adacel is approved for use in persons 10 through 64 years of age with no reported adverse event; Initial information received on 23-Mar-2026 regarding an unsolicited valid non-serious case received from a reporter. This case involves a 76- years old female patient who had prescription by healthcare professional (HCP) of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine (Adacel), with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. On an unknown date, the patient received a 0.5 mL once dose of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine, suspension for injection (batch and expiry: unknown) (strength: unknown) via intramuscular route in an unknown administration site for helps protect against tetanus, diphtheria, and pertussis diseases (Immunisation). The patient was 76 years old and per package insert, Adacel was approved for use in persons 10 through 64 years of age (Off label use, onset: unknown, latency: unknown). It was intentional: yes, for a therapeutic purpose: no, at the initiative of: HCP. Action taken: not applicable.
Comments: NONE